SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001521536-11-000266
Filing Date
2011-09-21
Accepted
2011-09-21 17:30:58
Documents
9

Document Format Files

Seq Description Document Type Size
1 q1100170_s1-biozone.htm S-1 2035641
2 q1100170_ex5-1.htm EX-5.1 7871
3 q1100170_ex23-2.htm EX-23.2 7868
  Complete submission text file 0001521536-11-000266.txt   3118751

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE bzne-20110630.xml EX-101.INS 144687
5 XBRL SCHEMA FILE bzne-20110630.xsd EX-101.SCH 10639
6 XBRL CALCULATION FILE bzne-20110630_cal.xml EX-101.CAL 27401
7 XBRL DEFINITION FILE bzne-20110630_def.xml EX-101.DEF 7708
8 XBRL LABEL FILE bzne-20110630_lab.xml EX-101.LAB 79973
9 XBRL PRESENTATION FILE bzne-20110630_pre.xml EX-101.PRE 56611
Mailing Address 4400 BISCAYNE BLVD SUITE 850 MIAMI FL 33137
Business Address 4400 BISCAYNE BLVD SUITE 850 MIAMI FL 33137 800-689-0930
BIOZONE PHARMACEUTICALS, INC. (Filer) CIK: 0001412486 (see all company filings)

IRS No.: 205978559 | State of Incorp.: NV | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-176951 | Film No.: 111101953
SIC: 7389 Services-Business Services, NEC